First-in-class Anti-tumor Agent ONC201 Induces Apoptosis in Hematological Malignancies with Wild Type and Mutant p53

MLA

Hans C. Lee, et al. “First-in-Class Anti-Tumor Agent ONC201 Induces Apoptosis in Hematological Malignancies with Wild Type and Mutant P53.” Clinical Lymphoma Myeloma and Leukemia, vol. 15, Sept. 2015, p. S73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........40db0e705eb226f60a37bf608e9c419a&authtype=sso&custid=ns315887.

APA

Hans C. Lee, Sattva S. Neelapu, Peter P. Ruvolo, Wencai Ma, Yoko Tabe, Gautam Borthakur, Rodrigo Jacamo, Michael Wang, Zhiqiang Wang, Dos D. Sarbassov, Kensuke Kojima, Robert N. Miranda, Marina Konopleva, R. Eric Davis, Dhruv Chachad, Jo Ishizawa, Michael Andreeff, Zhihong Zeng, Robert Z. Orlowski, … Timothy J. McDonnell. (2015). First-in-class Anti-tumor Agent ONC201 Induces Apoptosis in Hematological Malignancies with Wild Type and Mutant p53. Clinical Lymphoma Myeloma and Leukemia, 15, S73.

Chicago

Hans C. Lee, Sattva S. Neelapu, Peter P. Ruvolo, Wencai Ma, Yoko Tabe, Gautam Borthakur, Rodrigo Jacamo, et al. 2015. “First-in-Class Anti-Tumor Agent ONC201 Induces Apoptosis in Hematological Malignancies with Wild Type and Mutant P53.” Clinical Lymphoma Myeloma and Leukemia 15 (September): S73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........40db0e705eb226f60a37bf608e9c419a&authtype=sso&custid=ns315887.